Nanoparticles As a Novel Key Driver for the Isolation and Detection of Circulating Tumour Cells

Overview

Journal Sci Rep

Specialty Science

Date 2024 Sep 29

PMID 39343959

Authors

Shahab Bashir

Muhammad Amn Zia

Madiha Shoukat

Imdad Kaleem

Shahid Bashir

Affiliations

Soon will be listed here.

Abstract

Circulating tumour cells (CTCs), derived from primary tumours, play a pivotal role in cancer metastasis by migrating into the peripheral bloodstream. These cells are paramount in clinical research, serving as early diagnostic markers for metastatic cancer. Analysing CTC counts and their biomarker characteristics can provide invaluable insights into tumour identification, profiling, and metastatic capabilities. However, the rarity and diverse nature of CTCs in the bloodstream present significant challenges to their isolation and detection, especially in the initial stages of metastasis. Recent advancements in nanotechnology have led to the development of innovative CTC separation and detection methods. This review focuses on applying nanoparticles, nanomaterials, and microfluidic platforms to simplify the isolation and detection of CTCs. The infusion of nanotechnology in this field marks a crucial turning point, enabling the necessary progress to advance CTC research.

Citing Articles

Minimal Residual Disease in Metastatic Soft Tissue Sarcoma.

Kournoutas I, Siontis B Curr Treat Options Oncol. 2025; .

PMID: 40072823 DOI: 10.1007/s11864-025-01303-x.

References

Jin X, Li H, Wang S, Kong N, Xu H, Fu Q . Multifunctional superparamagnetic nanoshells: combining two-photon luminescence imaging, surface-enhanced Raman scattering and magnetic separation. Nanoscale. 2014; 6(23):14360-70. DOI: 10.1039/c4nr04111a. View

Baranwal J, Barse B, Di Petrillo A, Gatto G, Pilia L, Kumar A . Nanoparticles in Cancer Diagnosis and Treatment. Materials (Basel). 2023; 16(15). PMC: 10420054. DOI: 10.3390/ma16155354. View

Xie J, Dong H, Chen H, Zhao R, Sinko P, Shen W . Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial. J Nanobiotechnology. 2015; 13:9. PMC: 4320453. DOI: 10.1186/s12951-015-0072-x. View

Kumari Y, Kaur G, Kumar R, Singh S, Gulati M, Khursheed R . Gold nanoparticles: New routes across old boundaries. Adv Colloid Interface Sci. 2019; 274:102037. DOI: 10.1016/j.cis.2019.102037. View

Park G, Kwon H, Kwak D, Park S, Kim M, Lee J . Full surface embedding of gold clusters on silicon nanowires for efficient capture and photothermal therapy of circulating tumor cells. Nano Lett. 2012; 12(3):1638-42. DOI: 10.1021/nl2045759. View

Cai W, Gao T, Hong H, Sun J . Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. 2013; 1:17-32. PMC: 3808249. DOI: 10.2147/nsa.s3788. View

Chehelgerdi M, Chehelgerdi M, Allela O, Pecho R, Jayasankar N, Rao D . Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023; 22(1):169. PMC: 10561438. DOI: 10.1186/s12943-023-01865-0. View

Gao Y, Gu S, Zhang Y, Xie X, Yu T, Lu Y . The Architecture and Function of Monoclonal Antibody-Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention. Small. 2016; 12(19):2595-608. DOI: 10.1002/smll.201600550. View

Li X, Li Y, Shao W, Li Z, Zhao R, Ye Z . Strategies for enrichment of circulating tumor cells. Transl Cancer Res. 2022; 9(3):2012-2025. PMC: 8797280. DOI: 10.21037/tcr.2020.01.17. View

10.

Qian W, Miao Z, Zhang X, Yang X, Tang Y, Tang Y . Functionalized reduced graphene oxide with aptamer macroarray for cancer cell capture and fluorescence detection. Mikrochim Acta. 2020; 187(7):407. DOI: 10.1007/s00604-020-04402-8. View

11.

Wang S, Wang H, Jiao J, Chen K, Owens G, Kamei K . Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew Chem Int Ed Engl. 2009; 48(47):8970-3. PMC: 2878179. DOI: 10.1002/anie.200901668. View

12.

Zhong X, Zhang H, Zhu Y, Liang Y, Yuan Z, Li J . Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy. Mol Cancer. 2020; 19(1):15. PMC: 6982393. DOI: 10.1186/s12943-020-1141-9. View

13.

Wang L, Asghar W, Demirci U, Wan Y . Nanostructured substrates for isolation of circulating tumor cells. Nano Today. 2014; 8(4):347-387. PMC: 4059613. DOI: 10.1016/j.nantod.2013.07.001. View

14.

Liu Y, Li R, Zhang L, Guo S . Nanomaterial-Based Immunocapture Platforms for the Recognition, Isolation, and Detection of Circulating Tumor Cells. Front Bioeng Biotechnol. 2022; 10:850241. PMC: 8964261. DOI: 10.3389/fbioe.2022.850241. View

15.

Capuozzo M, Ferrara F, Santorsola M, Zovi A, Ottaiano A . Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors. Cells. 2023; 12(22). PMC: 10670669. DOI: 10.3390/cells12222590. View

16.

Singh J, Jain K, Mehra N, Jain N . Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers. Artif Cells Nanomed Biotechnol. 2016; 44(7):1626-34. DOI: 10.3109/21691401.2015.1129625. View

17.

Kim D, Kim Y, Hong S, Kim J, Huh N, Lee M . Development of Lateral Flow Assay Based on Size-Controlled Gold Nanoparticles for Detection of Hepatitis B Surface Antigen. Sensors (Basel). 2016; 16(12). PMC: 5191134. DOI: 10.3390/s16122154. View

18.

Das U, Banik S, Sajankila Nadumane S, Chakrabarti S, Gopal D, Kabekkodu S . Isolation, Detection and Analysis of Circulating Tumour Cells: A Nanotechnological Bioscope. Pharmaceutics. 2023; 15(1). PMC: 9864919. DOI: 10.3390/pharmaceutics15010280. View

19.

Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S . Smart nanoparticles for cancer therapy. Signal Transduct Target Ther. 2023; 8(1):418. PMC: 10622502. DOI: 10.1038/s41392-023-01642-x. View

20.

Bouche M, Hsu J, Dong Y, Kim J, Taing K, Cormode D . Recent Advances in Molecular Imaging with Gold Nanoparticles. Bioconjug Chem. 2019; 31(2):303-314. PMC: 7032998. DOI: 10.1021/acs.bioconjchem.9b00669. View